Inception Growth Acquisition Limited Announces Extension of Business Combination Period
Global Newswire by Notified: M&A
JUNE 11, 2025
The purpose of the extension is to provide additional time for the Company to complete a business combination.
Acquisitions Initial Public Offering Investment Manager 
Cooley’s 2023 Life Sciences M&A Year in Review: Potent Mix of Creativity and Resilience Spurs Activity Heading Into 2024
Cooley M&A
JANUARY 23, 2024
For example, in the biopharma space, AbbVie, Bristol Myers Squibb, AstraZeneca, and Roche each announced multiple big-ticket acquisitions in the fourth quarter – including Abbvie’s acquisition of ImmunoGen for $10.1 billion; Bristol Myer Squibb’s acquisition of RayzeBio for $4.1 billion and Cerevel Therapeutics for $8.7
Let's personalize your content